What pulmonologists think about the asthma–COPD overlap syndrome

International Journal of COPD

Volumn 10, Issue , 2015, Pages 1321-1330

  Miravitlles, Marc ^a,b   Alcázar, Bernardino ^c   Alvarez, Francisco Javier ^d   Bazús, Teresa ^e   Calle, Myriam ^f   Casanova, Ciro ^g   Cisneros, Carolina ^h   De Torres, Juan P ⁱ   Entrenas, Luis M ^j   Esteban, Cristóbal ^k   García Sidro, Patricia ^l   Cosio, Borja G ^m   Huerta, Arturo ⁿ   Iriberri, Milagros ^o   Izquierdo, José Luis ^p   López Viña, Antolín ^q   López Campos, José Luis ^b,d   Martínez Moragón, Eva ^r   de Llano, Luis Pérez ^s   Perpiñá, Miguel ^t   Ros, José Antonio ^u   Serrano, José ^v   Soler Cataluña, Juan José ^w   Torrego, Alfons ^x,y   Urrutia, Isabel ^k   Plaza, Vicente ^x,y   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c Respiratory Department   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^h Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

ⁱ UNIVERSITY CLINIC OF NAVARRA   (Spain)

^j HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^k HOSPITAL DE GALDAKAO   (Spain)

^l Department of Pneumology Hospital Universitario de La Plana   (Spain)

^m HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

ⁿ HOSPITAL CLÍNIC   (Spain)

^o HOSPITAL DE CRUCES   (Spain)

^p HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^q HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^r HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^s HOSPITAL UNIVERSITARIO LUCUS AUGUSTI   (Spain)

^t HOSPITAL UNIVERSITARIO LA FE   (Spain)

^u Hospital Clinico Universitario Virgen de la Arriaxa   (Spain)

^v Hospital Comarcal d'Inca   (Spain)

^w HOSPITAL ARNAU DE VILANOVA   (Spain)

^x HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^y UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

ACOS; Asthma; COPD; Guidelines; Survey

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; STEROID; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

ADULT; AIRFLOW; ARTICLE; ASTHMA; ASTHMA COPD OVERLAP SYNDROME; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MALE; MEDICAL HISTORY; MIDDLE AGED; PHYSICIAN ATTITUDE; PULMONOLOGIST; RISK FACTOR; SMOKING HABIT; SPANIARD; TREATMENT INDICATION; ADVERSE EFFECTS; ATTITUDE TO HEALTH; CONSENSUS; HEALTH PERSONNEL ATTITUDE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONOLOGY; QUESTIONNAIRE; SMOKING; SPAIN; SPECIALIZATION;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; ATTITUDE OF HEALTH PERSONNEL; BRONCHODILATOR AGENTS; CONSENSUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RISK FACTORS; SMOKING; SPAIN; SPECIALIZATION; SURVEYS AND QUESTIONNAIRES;

EID: 84937564455     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S88667     Document Type: Article

References (34)

1. Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9:24.
2. de Marco R, Cappa V, Accordini S, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J. 2012;39:883-892.
3. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379:1341-1351.
4. López-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. Lancet Respir Med. 2014;2:54-62.
5. Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with chronic fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:418-424.
6. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64:728-735.
7. Hardin M, Silverman EK, Barr RG, et al. The clinical features of overlap between COPD and asthma. Respir Res. 2011;12:127.
8. Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107:1053-1060.
9. Pleasants RA, Ohar JA, Croft JB, et al. Chronic obstructive pulmonary disease and asthma - patient characteristics and health impairment. COPD. 2014;11:256-266.
10. Rhee CK, Yoon HK, Yoo KH, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD. 2014;11:163-170.
11. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124:474-481.
12. Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48:331-337.
13. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol. 2014;50 Suppl 1:1-16.
14. Kovlizek V, Chlumsky J, Zindr V, et al. Chronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:189-201.
15. Kankaanranta H, Harju T, Kilpeläinen M, et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finish guidelines. Basic Clin Pharmacol Toxicol. 2015;116:291-307.
16. Global Initiative for Asthma, Global initiative for chronic Obstructive Lung Disease (GOLD). Asthma, COPD, and asthma-COPD overlap syndrome. 2014. Available from: http://www.goldcopd.org/asthma-copd-overlap.html. Accessed August 5, 2014.
17. UNICEF. Visualisation in Participatory Programme: A Manual for Facilitators and Trainers Involved in Participatory Group Events. Dhaka: UNICEF; 1993.
18. Miravitlles M, Andreu I, Romero Y, Sitjar S, Altés A, Anton E. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract. 2012;62:e68-e75.
19. [No authors listed]. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. A report of the conclusions of a Ciba guest symposium. Thorax. 1959;14:286-299.
20. [No authors listed]. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:S77-S120.
21. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163:1256-1276.
22. Lötvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127:355-360.
23. Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.
24. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598-604.
25. Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD. Identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48:86-98.
26. Barrecheguren M, Esquinas C, Miravitlles M. The asthma-COPD overlap syndrome (ACOS). Opportunities and challenges. Curr Opin Pulm Med. 2015;21:74-79.
27. Golpe R, Sanjuán López P, Cano Jiménez E, et al. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol. 2014;50:318-324.
28. Miravitlles M, Huerta A, Fernández-Villar JA, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes. 2014;12:120.
29. Fingleton J, Travers J, Williams M, et al. Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. J Allergy Clin Immunol. Epub March 4, 2015.
30. Menezes AM, de Oca MM, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype COPD-asthma. Chest. 2014;145:297-304.
31. Miravitlles M, Barrecheguren M, Roman-Rodriguez M. Frequency and characteristics of different clinical phenotypes of COPD. Int J Tub Lung Dis. 2015;19:992-998.
32. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med. 2008;102:50-56.
33. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J. 2007;14 Suppl B:5B-32B.
34. Nagai A, Aizawa H, Aoshiba K, et al. Guidelines for the Diagnosis and Treatment of COPD. 3rd ed. Tokyo: Japanese Respiratory Society; 2009.